Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class ASSE: 600276

"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Announcement on Obtaining Orphan Drug Designation from the US FDA

· Issued by Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Orphan Drug Designation from the US FDA

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A

All Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A news releases